Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Lunai Bioworks Inc. publishes a filing, an earnings call transcript or a press release.

Get LNAI alerts

About Mark Dybul

The proxy statement of Lunai Bioworks Inc. reports total compensation of $242,107 for Mark Dybul in fiscal 2025, including a base salary of $161,899. Disclosed compensation is on record for 5 fiscal years. Lunai Bioworks Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Lunai Bioworks Inc. includes David Weinstein (CEO and Board Member), Eric Leire (CEO), Maurice van Tilburg (CEO) and 7 others.

Affiliation history

Company network

Leadership on record at Lunai Bioworks Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Lunai Bioworks Inc. (LNAI) $161,899 $242,107
2024 Lunai Bioworks Inc. (LNAI) $325,282 $1,759,326
2021 Lunai Bioworks Inc. (LNAI) $430,000 $430,000
2020 Lunai Bioworks Inc. (LNAI) $430,000 $1,262,500
2019 Lunai Bioworks Inc. (LNAI) $165,000 $1,889,100

Recent activity

No call appearances or filed executive changes recorded yet.